Donepezil linked to cost savings in patients with Alzheimer's

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1277, 2001-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil linked to cost savings in patients with Alzheimer's

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 302, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Causes of Syncope in Patients with Alzheimer’s Disease Treated with Donepezil

By Bordier Philippe   Lanusse Stephane   Garrigue Stephane   Reynard Charlotte   Robert Frederic   Gencel Laurent   Lafitte Alexia  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 687-694

Adis International

Access to resources Recommend Favorite

Cardiovascular Effects and Risk of Syncope Related to Donepezil in Patients with Alzheimer's Disease

By Bordier Philippe   Garrigue Stephane   Lanusse Stephane   Margaine Julien   Robert Frederic   Gencel Laurent   Lafitte Alexia  

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 411-417

Adis International

Access to resources Recommend Favorite

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine

By Brett Hauber A.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 351-360

Adis International

Access to resources Recommend Favorite

Potential Savings in the Cost of Caring for Alzheimer's Disease: Treatment with Rivastigmine

By Linkins K.W.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 609-612

Adis International

Access to resources Recommend Favorite